ANI PHARMACEUTICALS INC - Common Stock (ANIP)

CUSIP: 00182C103

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock
Shares outstanding
22,278,088
Total 13F shares
19,963,692
Share change
+681,080
Total reported value
$1,336,584,283
Put/Call ratio
168%
Price per share
$66.95
Number of holders
226
Value change
+$48,405,121
Number of buys
107
Number of sells
93

Security key

00182C103

Report period

Q1 2025

Institutions

226

Top holders

10

Top shareholders of ANIP - ANI PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
MILLENNIUM MANAGEMENT LLC
13D/G 13F
Company
3.8%
818,341
$57,136,569 -$19,037,261 31 Mar 2025
BlackRock, Inc.
13F
Company
12%
2,738,572
$151,388,261 31 Dec 2024
13F
VANGUARD GROUP INC
13F
Company
5.9%
1,314,372
$72,658,484 31 Dec 2024
13F
STATE STREET CORP
13F
Company
3.3%
737,288
$40,757,281 31 Dec 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
3.1%
699,618
$38,674,883 31 Dec 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
3.1%
685,730
$37,905,950 31 Dec 2024
13F
Deep Track Capital, LP
13F
Company
2.9%
649,042
$35,879,042 31 Dec 2024
13F
Global Alpha Capital Management Ltd.
13F
Company
2.8%
624,550
$34,525,124 31 Dec 2024
13F
UBS Group AG
13F
Company
2.7%
594,810
$32,881,098 31 Dec 2024
13F
CITADEL ADVISORS LLC
13F
Company
2.7%
591,594
$32,703,317 31 Dec 2024
13F
Ranger Investment Management, L.P.
13F
Company
2.6%
577,738
$31,937,357 31 Dec 2024
13F
MACQUARIE GROUP LTD
13F
Company
2.5%
562,603
$31,101,000 31 Dec 2024
13F
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
13F
Company
2.2%
485,268
$26,825,615 31 Dec 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.9%
428,999
$23,720,094 31 Dec 2024
13F
TANG CAPITAL MANAGEMENT LLC
13F
Company
1.4%
317,500
$17,551,400 31 Dec 2024
13F
Assenagon Asset Management S.A.
13F
Company
1.4%
311,617
$17,226,188 31 Dec 2024
13F
THOMPSON SIEGEL & WALMSLEY LLC
13F
Company
1.3%
283,860
$15,692,000 31 Dec 2024
13F
AMERIPRISE FINANCIAL INC
13F
Company
1.2%
271,805
$15,025,381 31 Dec 2024
13F
JPMORGAN CHASE & CO
13F
Company
1.2%
268,050
$14,817,804 31 Dec 2024
13F
Aberdeen Group plc
13F
Company
1.1%
237,965
$13,154,705 31 Dec 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
1.1%
236,157
$13,054,759 31 Dec 2024
13F
DEUTSCHE BANK AG\
13F
Company
1%
232,328
$12,843,093 31 Dec 2024
13F
BANK OF MONTREAL /CAN/
13F
Company
1%
230,153
$12,722,859 31 Dec 2024
13F
MORGAN STANLEY
13F
Company
1%
226,578
$12,525,242 31 Dec 2024
13F
NOMURA HOLDINGS INC
13F
Company
0.96%
213,879
$11,823,231 31 Dec 2024
13F
ROYAL BANK OF CANADA
13F
Company
0.94%
210,266
$11,623,000 31 Dec 2024
13F
Soleus Capital Management, L.P.
13F
Company
0.92%
205,294
$11,348,652 31 Dec 2024
13F
NORTHERN TRUST CORP
13F
Company
0.92%
204,345
$11,296,192 31 Dec 2024
13F
MIZUHO MARKETS AMERICAS LLC
13F
Company
0.9%
200,618
$11,090,163 31 Dec 2024
13F
Invesco Ltd.
13F
Company
0.89%
197,545
$10,920,288 31 Dec 2024
13F
D. E. Shaw & Co., Inc.
13F
Company
0.88%
196,319
$10,852,514 31 Dec 2024
13F
LOOMIS SAYLES & CO L P
13F
Company
0.87%
194,185
$10,735,000 31 Dec 2024
13F
KENNEDY CAPITAL MANAGEMENT LLC
13F
Company
0.84%
186,275
$10,297,282 31 Dec 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.79%
175,800
$9,718,224 31 Dec 2024
13F
Sio Capital Management, LLC
13F
Company
0.72%
160,051
$8,847,619 31 Dec 2024
13F
BARCLAYS PLC
13F
Company
0.7%
157,060
$8,682,276 31 Dec 2024
13F
Russell Investments Group, Ltd.
13F
Company
0.63%
140,496
$7,766,617 31 Dec 2024
13F
Bank of New York Mellon Corp
13F
Company
0.56%
123,832
$6,845,449 31 Dec 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.43%
95,160
$5,260,446 31 Dec 2024
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.42%
93,777
$5,183,992 31 Dec 2024
13F
GREAT LAKES ADVISORS, LLC
13F
Company
0.33%
74,227
$4,103,269 31 Dec 2024
13F
Walleye Capital LLC
13F
Company
0.32%
72,009
$3,980,658 31 Dec 2024
13F
RAYMOND JAMES FINANCIAL INC
13F
Company
0.32%
70,826
$3,915,606 31 Dec 2024
13F
MARATHON CAPITAL MANAGEMENT
13F
Company
0.31%
69,895
$3,863,796 31 Dec 2024
13F
OBERWEIS ASSET MANAGEMENT INC/
13F
Company
0.29%
65,600
$3,626,368 31 Dec 2024
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.27%
60,248
$3,330,509 31 Dec 2024
13F
Qube Research & Technologies Ltd
13F
Company
0.27%
59,920
$3,312,378 31 Dec 2024
13F
RICE HALL JAMES & ASSOCIATES, LLC
13F
Company
0.26%
58,968
$3,259,751 31 Dec 2024
13F
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC
13F
Company
0.26%
57,180
$3,160,910 31 Dec 2024
13F
Rubric Capital Management LP
13F
Company
0.25%
56,671
$3,132,773 31 Dec 2024
13F

Institutional Holders of ANI PHARMACEUTICALS INC - Common Stock (ANIP) as of Q1 2025

As of 31 Mar 2025, ANI PHARMACEUTICALS INC - Common Stock (ANIP) was held by 226 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,963,692 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, Global Alpha Capital Management Ltd., CITADEL ADVISORS LLC, STATE STREET CORP, Deep Track Capital, LP, GOLDMAN SACHS GROUP INC, DIMENSIONAL FUND ADVISORS LP, and Ranger Investment Management, L.P.. This page lists 228 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2025 vs Q4 2024 Across Filers

Q4 2024 holders
204
Q1 2025 holders
226
Holder diff
22
Investor Q4 2024 Shares Q1 2025 Shares Share Diff Share Chg % Q4 2024 Value $ Q1 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .